v3.26.1
Nature of Business and Liquidity - Additional Information (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 04, 2026
Sep. 30, 2025
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Line Items]                  
Aggregate gross proceeds from sale of common stock, convertible preferred stock and convertible notes             $ 401,800    
Aggregate gross proceeds from issuance and sale of common stock             688,800    
Net loss     $ (37,095) $ (23,517) $ (19,411) $ (23,880) (60,612) $ (43,291) $ (87,000)
Accumulated deficit     285,088       285,088   $ 224,476
Cash, cash equivalents and marketable securities     418,600       418,600    
Common Stock                  
Organization, Consolidation and Presentation of Financial Statements [Line Items]                  
Number of shares sold       2,250,986          
Underwritten Public Offering | Common Stock                  
Organization, Consolidation and Presentation of Financial Statements [Line Items]                  
Number of shares sold   11,108,055              
Aggregate gross proceeds from offering   $ 199,900              
ATM Offering | Common Stock                  
Organization, Consolidation and Presentation of Financial Statements [Line Items]                  
Number of shares sold 2,250,986                
Aggregate gross proceeds from offering $ 87,100                
March 2026 Sales Agreement | Common Stock                  
Organization, Consolidation and Presentation of Financial Statements [Line Items]                  
Amount available to sell and issue shares of common stock     $ 250,000       $ 250,000